Kenvue Brands LLC, the maker of Tylenol®, issued the following statement in response to today’s filing by the Office of the Attorney General of Texas:
We are taking immediate legal action to stop the plaintiffs’ attorneys representing the State of Texas from continuing to drive these reckless and scientifically unsound theories.
These politically and financially motivated actions will have a detrimental impact on public health for our consumers in this state, particularly women and children.
We will do everything in our power to stand up for sound, credible science.
The Facts
- Does acetaminophen cause autism or ASD? No. Current scientific evidence does not support a causal relationship.
- Do leading medical authorities recommend acetaminophen during pregnancy when medically indicated and used as directed? Yes.
- Is Tylenol allowed to be marketed as safe and effective? Yes. FDA has determined that over-the-counter medicines containing acetaminophen, like Tylenol®, are safe and effective and can be marketed per the product labeling.
- What is the dividend payment referenced in this filing? This is the regular quarterly dividend we have paid to shareholders since we became a public company in 2023.
What is Happening Here
We believe this is gamesmanship orchestrated by the plaintiffs’ bar in a desperate attempt to line their pockets by reviving legal claims that have already been thrown out of federal court.
To be clear: there is no sound science that supports this action, nor will this protect Texas women and children.
Seeking to usurp the role of FDA, plaintiffs’ lawyers continue to drive scientifically unsound theories and are fueling a dangerous, coordinated misinformation campaign about acetaminophen, an ingredient medical experts recognize as the safest pain reliever option available to women as needed throughout the entirety of their pregnancies.
What Science Shows
Rigorous, independent research, endorsed by leading medical professionals and global health regulators, confirms that there is no proven link between taking acetaminophen and autism.
FDA has evaluated the scientific evidence for over a decade and repeatedly concluded the data does not support a causal link between taking acetaminophen and autism. This position is as recent as what was explained in FDA’s Notice to Physicians. FDA also previously evaluated, and rejected, updating the pregnancy warning on the product label.
Our Commitment
Nothing is more important to us than the health and safety of the people who use our products.
We stand behind the safety of Tylenol® and will continue to pursue all options to put an end to these financially and politically motivated tactics that only seek to benefit plaintiffs’ attorneys and not women and children.
Cautions Concerning Forward-Looking Statements & Opinions
This statement contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, litigation related to acetaminophen, as well as opinions and beliefs about scientific evidence. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue Brands LLC and its affiliates.
A list and descriptions of risks, uncertainties and other factors can be found in Kenvue Inc.’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request. Kenvue Brands LLC and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.